Functional Brands, Inc. (MEHA) Fair Value 2026

MEHA · Medicinal Chemicals & Botanical Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.0 /10

32 fundamental signals · 3 models active

Value Trap Risk

(—/100)

Quick Summary — As of 2026-07-15, Functional Brands, Inc. (MEHA) trades at $0.01, approximately 83% below CirclFi’s Bayesian DCF fair value of $0.03. QOC: 5.0/10. 3/13 models active.

Key Facts

Ticker
MEHA
Price
$0.01
Quality Score
5.0/10
Value Trap Risk
—/100
Models Active
3/13
Last Updated
Strength: Bayesian DCF suggests +492.1% upside with 59% confidence
Risk: Below-average Quality Score of 5.0/10 signals weak fundamentals

Is Functional Brands, Inc. (MEHA) Undervalued or Overvalued in 2026?

According to CirclFi’s 3-model valuation engine, Functional Brands, Inc. (MEHA) appears undervalued as of : the median of 3 independent fair value estimates is $0.03, 471.9% above the current price of $0.01. Estimates range from $0.00 to $0.03. MEHA scores 5.0/10 on fundamental quality and —/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Functional Brands, Inc. Stock in 2026? →

Valuation Matrix

3 Intrinsic Value Models vs. Current Price ($0.01)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$0.03 +492.1%
Markov DDM
Medium Conviction
$0.03 +471.9%
EROIC Spread
Medium Conviction
$0.00 -18.6%

All Models Active

All 3 models are displayed above.

What Is Functional Brands, Inc. (MEHA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Functional Brands, Inc.'s intrinsic value is estimated at a composite fair value of $0.02. While the stock appears modestly undervalued at $0.01 (implied upside of +315.1%), our analysis suggests a thinner margin of safety across 2 of 3 bullish models. Notably, Bayesian DCF sees the most upside at +492.1% (fair value: $0.03), while EROIC is the most conservative at -18.6% ($0.00). The spread between these extremes — +510.6% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About MEHA?

3 of 13 models are currently active for MEHA. Of these, 2 models suggest upside while 1 model suggests overvaluation. The Bayesian DCF estimates MEHA's intrinsic value at $0.03, implying +492.1% upside from the current price. See which stocks rank higher →

How Does MEHA Rank in Medicinal Chemicals & Botanical Products?

Among 17 Medicinal Chemicals & Botanical Products stocks, MEHA ranks #11 by Quality of Company score. CirclFi's QOC score of 5.0/10 evaluates 32 fundamental signals. A score of 5.0 reflects mixed fundamentals.

Within the Medicinal Chemicals & Botanical Products space, Functional Brands, Inc. competes in an environment where margin expansion trajectory often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is MEHA a Value Trap?

The Value Trap algorithm is not active for MEHA. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

3 of 13 models are active for Functional Brands, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Functional Brands, Inc. is rated at 5.0/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

The gap between the most bullish and bearish model spans +510.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MEHA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MEHA's 3 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Functional Brands, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medicinal Chemicals & Botanical Products Stocks Should You Also Analyze?

8 related Medicinal Chemicals & Botanical Products stocks with 13-model coverage

Read investment analysis: NAGE · FTLF · USNA · BTMD · TLRY

Frequently Asked Questions About Functional Brands, Inc.

What is Functional Brands, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Functional Brands, Inc. (MEHA) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.03. The Quality of Company score is 5.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MEHA overvalued or undervalued right now?

At $0.01, 2 of 3 active models suggest MEHA may be undervalued, while 1 indicate potential overvaluation. The median of all 3 fair value estimates is $0.03, 471.9% above the current price of $0.01 — a consensus view that MEHA is undervalued. The assessment depends on which methodology best fits Functional Brands, Inc.'s business model in Medicinal Chemicals & Botanical Products.

What does a Quality of Company score of 5.0 mean for MEHA?

Functional Brands, Inc.'s QOC of 5.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on MEHA?

CirclFi analyzes MEHA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 3 of 13 are active for this stock. Read the full methodology →

Is MEHA a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for MEHA at this time. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 3-model valuation engine, Functional Brands, Inc. (MEHA) has a median fair value of $0.03 — 471.9% above the current price of $0.01 — as of 2026-07-15.” Source: circlfi.com/stock/MEHA/ · Methodology